GGrantIndex
Sort

89,613 grants matching depression

A Cognitive Risk Calculator and Screening tool for Primary Care Settings

$1,076,444
Darlene Floden · Cleveland Clinic Lerner Com-Cwru · R33 · FY2022 · AG

Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia

$1,075,515
Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS

Longitudinal Impact of Air Pollution on Mental Health and Neuroimaging Outcomes during Adolescence in the Cincinnati Combined Childhood Cohorts (C4)

$1,074,630
Kimberly Yolton · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · ES

Imaging-guided tDCS therapy in major depression

$1,074,312
Katherine L Narr · University Of California Los Angeles · R61 · FY2018 · MH

1/2 Large-scale, single-cell characterization of molecular and cellular networks of mood regulation circuitry in major depressive disorder

$1,074,074
Thomas Michael Hyde · Lieber Institute, Inc. · R01 · FY2025 · MH

Population-Based Epidemiologic Research

$1,073,815
Kathleen R Merikangas · National Institute Of Mental Health · ZIA · FY2021 · MH

Using Immersive Virtual Reality and Media Literacy to Enhance Adolescents' Coping Skills in the Face of Traumatic Online Experiences

$1,073,590
Brendesha Marie Tynes · University Of Southern California · R01 · FY2023 · HD

Resilience Mechanisms Underlying Racial/Ethnic Disparities in Alzheimer’s Disease

$1,073,571
Adam M Brickman · Columbia University Health Sciences · R01 · FY2020 · AG

Understanding evoked and resting-state fMRI through multi scale imaging

$1,073,150
R. Todd Constable · Yale University · R01 · FY2016 · MH

VIGOR: Virtual Genome Center for Infant Health

$1,073,077
Timothy Wei-Wen Yu · Boston Children'S Hospital · R01 · FY2022 · HG

Neurocomputational studies of mood-related momentum dynamics linking reward learning, valuation and responsivity

$1,073,009
Alexandre Y. Dombrovski · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · MH

Symptoms Clusters in Oncology Patients Receiving Chemotherapy

$1,072,714
Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2009 · CA

An Ecosystem of Technology and Protocols for Adaptive Neuromodulation Research in Humans

$1,072,354
Kai Miller · Mayo Clinic Rochester · U01 · FY2025 · NS

Oxygen Mapping System for Enhanced Colonoscopic Neoplasm Detection

$1,072,220
Jason Matthew Zand · Surgisense Corporation · R44 · FY2015 · CA

BDNF Regulation: Roles in Plasticity and Neuroprotection

$1,072,162
University Of California Irvine · P01 · FY2005 · NS

A Prospective Longitudinal Study of PANDAS

$1,071,919
Yale University · R01 · FY2003 · MH

CDU/UCLA Project EXPORT Center

$1,071,267
David Sane Martins · Charles R. Drew University Of Med & Sci · P20 · FY2015 · MD

Neurocomputational studies of mood-related momentum dynamics linking reward learning, valuation and responsivity

$1,071,233
Alexandre Y. Dombrovski · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · MH

Collaborative Approach for Asian Americans and Pacific Islanders Research and Education (CARE) in Alzheimer’s Disease and Related Dementias.

$1,071,215
Van My Ta Park · University Of California, San Francisco · R24 · FY2020 · AG

Neonatal Seizure Registry Developmental Functional EValuation (NSR-DEV)

$1,071,157
Hannah Cranley Glass · University Of California, San Francisco · R01 · FY2022 · NS

Assessing Cultures of Recovery in Tribal Communities

$1,070,922
Martina Whelshula · Healing Lodge Of The Seven Nations · S06 · FY2023 · GM

Behavioral telehealth in low-resource primary care settings for anxiety and depression in youth: A randomized effectiveness-implementation study

$1,070,654
V Robin Weersing · San Diego State University · R01 · FY2023 · MH

Children at High and at Low Risk for Depression

$1,070,642
Myrna M Weissman · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2012 · MH

Genomic and Epigenomic Mechanisms of Maternal E-Cigarette induced Abnormal Brain Development

$1,070,336
Charles Wang · Loma Linda University · U01 · FY2024 · DA

Orally-Bioavailable Peroxynitrite Decomposition Catalyst Targeting Post-Surgical Pain

$1,070,335
Scott L Dax · Cersci Therapeutics, Inc. · R44 · FY2018 · DA